Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Refine your Search
|
Title
|
Publication Date
|
Price
|
Relevance
|
|
OSI Pharmaceuticals, Inc.-Deals & Alliances Report
|
Mar 2011 |
£380 |
100% |
AVEO Pharmaceuticals, Inc. – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
80% |
|
Companion Diagnostics
|
Sep 2011 |
£2,655 |
72% |
Biotech M&A and Licensing Strategies
Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
|
Apr 2011 |
£2,215 |
68% |
Non-Small Cell Lung Cancer - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
65% |
|
Pancreatic Cancer Drugs
|
Apr 2010 |
£2,180 |
64% |
Nucleic Acid Aptamers for Diagnostics and Therapeutics
Global Markets
|
Mar 2010 |
£3,065 |
63% |
|
Molecular Diagnostics
|
Oct 2010 |
£2,845 |
63% |
|
Prostate Cancer Therapeutics
|
Apr 2009 |
£2,500 |
63% |
Prostate Cancer Therapeutics
A Global Market Perspective
|
Nov 2009 |
£1,895 |
61% |
|
Genetic Testing
|
Jan 2011 |
£2,845 |
58% |
|
Bioinformatics
|
Jan 2011 |
£3,130 |
57% |
|
United States Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015
|
May 2009 |
£1,580 |
49% |
|
Cancer Therapies
|
Oct 2011 |
£2,845 |
45% |
Patient Monitors: Equipment & Accessories
A Global Market Overview
|
Mar 2011 |
£2,505 |
42% |
